The study successfully achieved its primary objective with an 89.5% response rate at study day 8 in Alinia-treated patients compared to 82.4% for metronidazole-treated patients. 142 patients were
In the 10-day monotherapy trial, patients taking MK-0518 achieved a 98% reduction in HIV-RNA across all dosages tested, and at least half achieved HIV-RNA copies of 400 per
IGN311, a humanized monoclonal antibody targeting the Lewis Y antigen, is being developed by Aphton’s subsidiary, Igeneon AG, as a potential new therapy for the treatment of cancer.
The study is designed to evaluate the safety, pharmacokinetic profile and antitumor activity of escalating doses of SGN-33, and is expected to enroll up to 60 patients at
Vernalis will pay an initial consideration of $29.5 million, payable in Vernalis shares and assume certain of Cita’s liabilities. Vernalis may also pay up to a further $35
The change of label shows that simultaneous administration of Lexiva in combination with Nexium (esomeprazole) does not result in lowering of blood levels of Lexiva. Drug interactions that
Whilst acknowledging the potential of the drug, a majority of committee members suggested that more prospective data on the Certican/cyclosporine combination regimen is needed to determine the optimal
Novartis Ophthalmics is recalling five lots of GenTeal gel, a non-prescription drug product used to relieve dryness of the eye. The five lots include about 142,500 tubes that
The transaction was approved by 84.8% of the votes cast by all securityholders, and 82.4% of votes cast by minority common shareholders. In addition, 82.8% of the votes
The phase I clinical trial recruited 41 patients with advanced solid tumors and was designed to examine the safety, tolerability, and pharmacokinetics of escalating doses of SNS-595. Results
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.